Study guide

9.3 Musculoskeletal Symptoms

Certified Hospice and Palliative Nurse CHPN

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility, Fees, Windows, and Retakes 1.3 Scoring, Test-Day Rules, and Remote Proctoring 1.4 Recertification: HPAR and the Situational Judgment Exercise

2 Chapter 2: Assessment, Goals, and Care Planning

2.1 Goals of Care and Shared Decision Making 2.2 Interdisciplinary Care Planning and Ongoing Evaluation 2.3 Prognostic and Functional Assessment Tools 2.4 Levels of Care and Care-Setting Transitions

3 Chapter 3: Life-Limiting Disease Progression I

3.1 Cancer, Hematologic, and Paraneoplastic Complications 3.2 Heart Failure and Cardiac Disease Progression 3.3 Pulmonary Disease Progression 3.4 Neurologic Disease Progression

4 Chapter 4: Disease Progression II and Imminent Death

4.1 Dementia, Frailty, and Feeding Decisions 4.2 Renal, Hepatic, and Endocrine Trajectories 4.3 Indicators of Imminent Death

5 Chapter 5: Pain Assessment

5.1 Pain Types, Etiology, and Syndromes 5.2 Verbal and Nonverbal Pain Assessment and Scales 5.3 Factors That Influence the Pain Experience

6 Chapter 6: Pharmacologic Pain Management

6.1 Opioid and Non-Opioid Analgesics by Pain Type and Severity 6.2 Adjuvant Analgesics 6.3 Titration, Baseline Dosing, and Breakthrough Pain 6.4 Equianalgesic Conversion and Route Changes

7 Chapter 7: Nonpharmacologic Pain and Opioid Safety

7.1 Nonpharmacologic Pain Interventions 7.2 Complementary and Integrative Pain Therapies 7.3 Opioid Adverse Effects, Neurotoxicity, and Rotation

8 Chapter 8: Neurological, Cardiovascular, and Respiratory Symptoms

8.1 Neurological Symptoms 8.2 Delirium and Terminal Restlessness 8.3 Cardiovascular Symptoms 8.4 Respiratory Symptoms: Dyspnea, Cough, and Secretions

9 Chapter 9: Gastrointestinal, Genitourinary, and Musculoskeletal Symptoms

9.1 Gastrointestinal Symptoms 9.2 Genitourinary Symptoms 9.3 Musculoskeletal Symptoms

10 Chapter 10: Skin, Metabolic, Hematologic, and Psychospiritual Symptoms

10.1 Skin and Mucous Membrane Symptoms 10.2 Nutritional and Metabolic Symptoms 10.3 Immune and Hematologic Symptoms 10.4 Psychosocial, Emotional, and Spiritual Symptom Burden

11 Chapter 11: Advance Care Planning, Benefits, and Safety

11.1 Advance Care Planning and Life-Sustaining Therapies 11.2 Hospice and Palliative Benefits under Medicare, Medicaid, and Private Insurance 11.3 Patient Safety: Environmental, Physical, and Socioemotional

12 Chapter 12: Communication, Culture, and Psychosocial Support

12.1 Communication Techniques, Barriers, and Family Meetings 12.2 Cultural Humility and Spiritual Needs 12.3 Psychosocial Needs and IDG Participation

13 Chapter 13: Caregiver Education and Medication Management

13.1 Medication Management and Controlled Substances 13.2 Caregiver and Family Self-Care 13.3 Teaching End-Stage Disease, Pain, and Symptom Plans 13.4 Caregiver Skills, DME, Supplies, and Services

14 Chapter 14: Grief, Death, and End-of-Life Ethics

14.1 Grief, Loss, and Bereavement 14.2 Support at the Time of Death and Post-Mortem Care 14.3 Ethical Issues Related to End of Life

15 Chapter 15: Medicare Hospice Compliance and National Standards

15.1 Medicare Hospice Benefit and Conditions of Participation 15.2 Hospice Eligibility, Admission, and Recertification 15.3 National Hospice and Palliative Care Standards 15.4 National Consensus Project Clinical Practice Guidelines

16 Chapter 16: Legal, Professional Practice, Quality, and Policy

16.1 Legal Regulations: CMS, HIPAA, and OSHA 16.2 Professional Boundaries and Ethics 16.3 QAPI, Self-Care, and Precepting 16.4 Policy, Delivery, and Reimbursement Trends

9.3 Musculoskeletal Symptoms

Key Takeaways Explain This Topic AI

Pathologic fracture care starts with stabilization and pain control; radiation and surgery follow only when prognosis and goals support them.

Bone-metastasis pain is mechanism-matched: NSAID or dexamethasone when safe, a strong opioid, and palliative radiation; bisphosphonates and denosumab are a months-of-life context, not an acute-fix-the-fracture drug.

Dexamethasone is a bone-pain adjuvant here; the spinal cord-compression emergency pathway was already taught in Chapter 8.

Do not stretch a pathologic femur as if it were a cramp, and do not splint a calf cramp as a fracture; baclofen or a benzodiazepine treat spasm after the bone is cleared.

New level-specific weakness is not automatically dying; use two-person or lift transfers and never pull on a metastatic humerus.

Last updated: August 2026

9.3 Musculoskeletal Symptoms

Domain 3 letter F is musculoskeletal : pathologic fracture, bone pain, spasm, cramps, weakness, deconditioning, and safe movement. Spinal cord compression and the dexamethasone-plus-imaging pathway already live in Chapter 8; this section is bone metastases, the broken bone, and the transfer . Passing remains a scaled score of 500 . Drugs remain generic ( dexamethasone , ibuprofen , morphine , zoledronic acid , baclofen ).

Pathologic fracture: stabilize first, then match treatment to goals

A pathologic fracture occurs through bone weakened by metastasis, myeloma, or severe osteoporosis. Femur, humerus, vertebrae, and pelvis are the usual hospice sites. The first nursing action is stop unsafe movement and stabilize : pillows, splint, traction as ordered, log-roll for spine, no yanking on a metastatic arm. Pain control is an opioid plus an anti-inflammatory adjuvant when organs allow (Chapter 6). Then match disease-modifying options to prognosis and goals .

Palliative radiation therapy treats local bone pain and can reduce local tumor. For many painful bone metastases, a single fraction (commonly 8 Gy in published palliative trials) is not inferior to longer courses for pain relief and is kinder when travel is hard and life is short.

Orthopedic surgery (intramedullary nailing of a femur, pinning, decompression) is for patients with weeks to months , adequate performance status, a lesion that hardware can actually help, and goals that include mobility or a bed-to-chair life. Oncology uses cortical-involvement and pain grading (Mirels-type thinking) to decide prophylactic fixation before the bone snaps; CHPN items more often present the bone that already failed.

If the patient is imminently dying , surgery is not comfort. Splint, medicate before turns, and teach the family that the “repair” is positioning, not the operating room.

Bone pain: NSAID, steroid, opioid, radiation, bisphosphonate context

Osteolytic and mixed bone metastases generate prostaglandins and periosteal stretch. Mechanism-matched drugs:

An NSAID if platelets, GI mucosa, and glomerular filtration rate can tolerate it.

Dexamethasone when an NSAID is unsafe or when there is inflammatory bone pain or liver-capsule stretch. Chapter 8 already taught dexamethasone for cord compression ; here the same steroid is a bone-pain adjuvant , not only a cord drug. New back pain plus weakness still triggers the cord pathway—do not “only treat bone pain” past a sensory level.

A strong opioid for moderate-to-severe intensity. Incident pain around transfers needs a premedication plan, not a lecture to lie still.

Radiation as above.

Bone-modifying agents — zoledronic acid , pamidronate , denosumab —reduce skeletal-related events in patients with months of expected survival. They do not knit an acute fracture today. They carry renal limits (zoledronic acid), hypocalcemia , flu-like infusion reactions, and osteonecrosis of the jaw . In the last days to a short two-week hospice enrollment, starting a bisphosphonate is usually the wrong use of a visit. In a still-ambulatory patient with prostate or breast metastases and a longer palliative course, they remain part of the oncology context you should recognize.

Spasm, cramps, and the fracture-versus-spasm exam trap

Muscle spasm is involuntary contraction: after a stroke, in amyotrophic lateral sclerosis or spinal disease, around a joint, or from a pulled catheter. Baclofen , a benzodiazepine such as diazepam or lorazepam , stretching, heat, and positioning treat spasm. Cramps at night in dying or diuretic-treated patients often track potassium, magnesium, and volume ; stretch the muscle, replete electrolytes when labs and goals support venipuncture, and do not diagnose a new femur fracture from a calf cramp.

The exam trap is calling a pathologic femur fracture “spasm” and stretching the leg, or calling myoclonus from opioid metabolites (Chapters 7 and 8) a “cramp” and giving more morphine.

Fracture versus spasm table

Feature Pathologic fracture Muscle spasm or cramp

Trigger Weight bearing, transfer, fall, or spontaneous through a known metastasis Stretch, fatigue, electrolyte shift, upper-motor-neuron disease

Exam Point tenderness, deformity, inability to bear weight, shortened or rotated limb Palpable tight muscle, no bony deformity, often relief with stretch

Wrong move Transfer without stabilization; “walk it off” Splinting a cramp as a femur and withholding stretch forever

Right move Stabilize, opioid plus NSAID or steroid if safe, radiation or surgery if goals Stretch, heat, baclofen or benzodiazepine, electrolytes, treat the neurologic cause

Related look-alikes Cord compression (weakness, sensory level, bowel or bladder change)—Chapter 8 Opioid myoclonus (multifocal jerks)—rotate the opioid, do not stretch a fracture

Weakness versus dying

Weakness is not automatically “they are dying.” Reversible or semi-reversible causes the CHPN registered nurse is expected to name: cord compression , hypercalcemia , anemia , hypokalemia , steroid myopathy (proximal, after prolonged dexamethasone), infection, and deconditioning . Global decline with mottling, Cheyne–Stokes respirations, cool extremities, and decreasing consciousness is the dying process (Chapter 4). Treating dying as a potassium problem delays comfort; treating cord compression as “just dying” misses a last window for dexamethasone and radiation.

Deconditioning and activity intolerance are Domain 3-F items too: energy conservation, therapy when goals include function, and not promising a gym program to a patient whose trajectory is days. Immobility still produces pressure injury (Chapter 10), constipation, and retention; the musculoskeletal add-on is do not cause the next fracture on the way to preventing a pressure injury .

Safe transfers

Assume every patient with known bone metastases has a weight-bearing restriction until the team says otherwise. Use a gait belt only if the bone can take it; many hospice transfers need a two-person assist or a mechanical lift . Do not pull on the arms of a patient with humeral metastases. Log-roll spinal disease. Premedicate for incident pain before the move. Teach family that a cracked femur is not a failure of love—it is diseased bone—and that the next transfer will be planned, not hurried.

Loading diagram... Pathologic fracture versus spasm versus dying weakness